Pages
Products
AAV5-CAG-NLuc-2A-mCherry

AAV5-CAG-NLuc-2A-mCherry

Cat.No. :  AAV00509Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 5 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Cat. No. AAV00509Z
Description AAV serotype 5 particles express 2A-linked NanoLuc luciferase (NLuc) reporter and mCherry reporter under the control of CAG promoter.
Reporter mCherry, NLuc
Serotype AAV Serotype 5
Target Gene NLuc-2A-mCherry
Application

1. Determination of optimal MOI (multiplicity of infection), administration methods etc.

2. Detection of the infection efficiency of the AAV serotype against a specific cell type or tissue.

3. Using reporter genes to visualize the distribution and expression of AAV vectors in live animals, helping assess the biodistribution and persistence of gene delivery.

Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Publications

Q & A

Customer Reviews

Recombinant adeno-associated viruses (rAAV) are promising viral vectors for gene delivery applications. These viruses belong to the single-stranded DNA (ssDNA) packaged Parvoviridae and Dependovirus genera. Hundreds of AAV genotypes have been sequenced from multiple mammalian species, and to date, 12 serotypes (AAV1 to AAV12) have been defined for human and non-human primate isolates. Based on antigenic reactivity and sequence similarity, these 12 serotypes can be divided into eight genotypes, clades A to F, and clonal isolates AAV4 and AAV5. These groups are represented by AAV1 to AAV9, with AAV1 and AAV6 belonging to the same clade A due to their high sequence similarity and antigenic cross-reactivity. The sequence identity of representative members is approximately 55% to 99%, with AAV4 and AAV5 being the most divergent from each other and from other members. Transgenes packaged in the prototypical human serotype AAV2 have been effective in correcting genetic diseases of the eye, brain, muscle, liver, and lung in animal models and have been successfully used to treat blindness and muscular dystrophy in humans. However, other serotypes have shown improvements in gene delivery related to the capsid sequence in certain tissues compared to AAV2. For example, in studies packaging the same transgene, AAV5 was more effective than AAV2 in transducing neurons and lung tissue. At the apical surface of airway epithelial cells, AAV5 was 20-fold and 50-fold more potent than AAV2 in vivo and in vitro, respectively, and was as effective as AAV8 in expressing coagulation factor IX systemically for the treatment of hemophilia. These observations have fueled efforts to develop AAV5 as a vector for the treatment of genetic diseases.
Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Valuable tool

This product delivered exceptional performance in a variety of cell types. The AAV5-CAG-NLuc-2A-mCherry's versatility makes it a valuable tool for any gene expression study.

United States

09/04/2021

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction